To assess the clinical performance and usefulness of an on-line patient exposure meter installed on a neuroradiologic biplane imaging system.
PURPOSE:
To assess the clinical performance and usefulness of an on-line patient exposure meter installed on a neuroradiologic biplane imaging system.
MATERIALS AND METHODS:
A commercial on-line patient exposure meter was installed on each plane of a biplane neuroradiologic imaging system. The meter computed skin exposures on the basis of selected technique factors (tube potential and current) and information about patient location relative to the x-ray tube. Simulations were performed to measure the system accuracy with an angiographic anthropomorphic head phantom with the skin exposures measured with an ionization chamber. Skin doses were computed for 114 consecutive patients who underwent diagnostic and interventional neuroradiologic procedures. RESULTS: Agreement between measured and computed skin exposures in fluoroscopy, plain radiography, and digital imaging was generally within 5% of the true skin dose. For all fluoroscopic and radiographic procedures, total median skin doses were 1.20 and 0.64 Gy for the frontal and lateral planes, respectively. In both planes, patient skin doses resulted primarily from digital subtraction angiographic acquisitions. In 29 (25%) patients, the skin dose exceeded 2.00 Gy, but no radiationinduced deterministic effects were observed. CONCLUSION: An on-line patient exposure meter can provide accurate radiation skin dose data in patients undergoing diagnostic and therapeutic neuroradiologic procedures.
I
NTERVENTIONAL neuroradiology increasingly involves therapeutic applications such as the embolization of arteriovenous malformations. This procedure involves long fluoroscopic exposure times and the acquisition of a large number of radiographs. As a result, there is a possibility for induction of deterministic radiation effects such as skin erythema and epilation (1,2). In general, modern, state-of-theart neuroradiologic imaging equipment was designed to minimize unnecessary patient exposure. Given the availability of optimal imaging equipment operated by trained experts, potential strategies for reduction of patient skin doses include reorientation of the x-ray beam, use of filters outside the specific region of interest, use of additional filtration, and fluoroscopy with a reduced pulse rate (3-5).
A radiation monitoring system that provides feedback of the cumulative patient dose rates and doses to the imaging equipment operators could play a role in ensuring that patient exposures are as low as reasonably achievable (6) . The benefits of a radiation monitoring system include identification of patients who may be at risk of experiencing deterministic radiation effects (7), provision of a formal record of patient exposure, and an increase in the radiologist's awareness of potentially high patient doses. In addition, the radiation monitoring system can serve as a powerful tool for empirical investigation of the tradeoffs between patient dose and corresponding image quality when radiographs are obtained of appropriate phantoms.
The purpose of this study was to assess the performance of an on-line patient exposure meter installed on a neuroradiologic biplane imaging system. In addition, patient skin dosimetry data were collected for the first 114 diagnostic and therapeutic neuroradiologic procedures performed after installation of the radiation monitoring system. The potential of the radiation monitoring system to help reduce patient dose was also assessed.
MATERIALS AND METHODS

Dosimetry System
The radiographic and fluoroscopic imaging system was a neurobiplane unit (CAS 30B/110A; Toshiba America Medical Systems, Tustin, Calif) integrated with a DFP 65A digital image acquisition system (Toshiba America Medical Systems). The digital image acquisition system was upgraded in July 1995 to a DFP2000A/A3 system (Toshiba America Medical Systems).
The upgraded system permitted the use of low-rate pulsed fluoroscopy (15 frames per second) and had the ability to modify the image intensifier radiation exposure for each selected protocol. An on-line patient exposure meter (PEMNET; Clinical Microsystems, Arlington, Va) was installed in April 1995 on each of the two planes of the imaging system. The dosimetry system is a microprocessor-based system that runs its own on-board software. Eight units can be networked to a single personal computer server by means of RS-121 interfaces, through which the units transfer patient exposure data to the personal computer server for storage and analysis or receive calibration information from the personal computer. The on-line patient exposure meter does not measure exposures directly, as is the case for dose area product meters (8) , but is passively hardwired to the x-ray generator to acquire the input signals listed in Table 1 . These input signals permit the computation of the skin exposures (and doses) that patients would receive if the same skin area is exposed continually to the x-ray beam. The on-line patient exposure meter computes patient skin exposures by using the x-ray tube radiation output at the selected technique factors (tube potential and current) together with information about the patient location relative to the x-ray tube and measured exposure times. The patient location is determined from the height of the examination table relative to the x-ray tube or by using an ultrasonic sensor at orientations where the position of the table is not relevant, as in lateral views. When the examination table intercepts the x-ray beam, x-ray attenuation by the table is taken into account. In the radiographic mode of operation, the skin exposure is computed, whereas in fluoroscopic modes, the skin exposure rate is determined. The real-time skin exposure rate, as well as the cumulative skin exposures, are displayed for each plane on two panel displays adjacent to the image display monitors and are readily visible by the neuroradiologic staff. In this study, all patient skin doses, obtained with the assumption that the same skin region is continually exposed to the x-ray beam, were termed "skin dose measurements."
Calibration
The x-ray tube radiation output was determined from exposure measurements obtained with an MDH 1015C radiation monitor (Radcal, Monrovia, Calif) with a 10 x 5-6 ionization chamber attached to the surface of an RSD RS-235 anthropomorphic phantom (Radiology Support Devices, Long Beach, Calif) as depicted in Figure 1 . For exposure calibrations, the ionization chamber was located at the isocenter of each C arm and in direct contact with the head phantom. For frontal (posteroanterior) exposures, the ionization chamber was located at the occipital area of the anthropomorphic phantom, while for lateral exposures the chamber was located next to the temporal bone of the phantom. All measurements of skin exposures used in the study included the contribution of backscattered radiation. A conversion factor of 2.58 x 10 -4 C/kg (1 R), corresponding to an absorbed dose of 9.3 mGy for muscle tissue, was used (9) .
X-ray generator signals fed to the on-line patient exposure meter were calibrated to read the correct technique factors, sourceto-patient distance, and tube orientation. The ultrasonic sensors attached to the side Relative to the floor plane C-arm height (cm)
Relative to the floor plane Ultrasonic distance measurement (cm)
Active after a C-arm rotation of 15 C-arm angulation ( o ) RAO and CAU rotations * CAU = craniocaudal, RAO = right anterior oblique.
of each x-ray tube collimator were calibrated to measure the x-ray source-topatient surface distance directly. Measured exposures were entered into the dosimetry unit and transferred to the personal computer server along with tube potential, tube current, and exposure time information. A calibration program on the personal computer server generated corresponding exposure curves (third and fourth degree polynomials) as a function of the applied tube potential and current at different modes of operation (ie, radiographic or fluoroscopic) and transferred the curve coefficients back to the system's microprocessor. Two calibrations were performed for each imaging plane, with and without the presence of the examination table, to derive the table attenuation coefficients.
Dosimetry System Evaluation
The accuracy of the on-line patient exposure meters was evaluated in all fluoroscopic and radiographic modes of operation. In fluoroscopy, the biplane unit may be operated in continuous or pulsed (15 or 30 frames per second) mode. In the radiographic mode, the unit may be operated in plain radiographic or digital subtraction angiographic mode. Each acquisition mode was investigated by using the geometry of a typical patient setup. The ionization chamber was attached to the anthropomorphic phantom as shown in Figure 1 . For frontal plane testing, table attenuation and positioning were taken into consideration. There was no table attenuation during testing of the lateral plane, and for this plane the source-to-patient distance was measured directly by the ultrasonic sensor.
Measured skin exposures were compared with the corresponding values computed by the on-line patient exposure meter for the following experimental arrangements: (a) variance of the tube potential and current over the ranges encountered in clinical imaging, as well as investigation of the effect of changing the electronic magnification and x-ray source-to-patient distance; (h) acquisition of fluoroscopic, plain radiographic, and digital images to simulate acquisition of extended series of neuroradiologic images; and (c) a single examination to maximize changes technically possible during the neuroradiologic procedure (eg, table height and location, source-to-pa- tient distance, collimation, C-arm rotation, image magnification, etc), thus providing an upper limit of system accuracy.
Patient Monitoring Protocol
After the introduction of the on-line patient exposure meter into clinical practice, dosimetry data were obtained for 114 consecutive patients who underwent neuroradiologic procedures during the 8-month period from April through December 1995. At the end of each patient examination, the exposure data accumulated were uploaded automatically to the personal computer server for subsequent analysis. The two planes of the neuroradiologic biplane system were termed "frontal" and "lateral" irrespective of their actual orientation relative to the patient; these orientations occasionally differed from the corresponding designated names used in the study. Dosimetry data were analyzed to provide cumulative doses for each acquisition mode for each plane for the total patient examination. In addition, the cumulative dose data were also obtained for discrete tube potential intervals, as well as for discrete dose rate intervals.
In radiographic and fluoroscopic modes, the on-line patient exposure meter calculated exposure rates by sampling the radiation technique factors every 5 msec and computing an average exposure rate every 800 msec. Additional information made available by the on-line patient exposure meter included the total fluoroscopic time, the number of times fluoroscopy was activated, the total number of radiographic planes.
images (plain radiographs and digital subtraction angiograms) obtained, and the average fluoroscopic and radiographic exposure rates for each patient examination. Table 2 shows ratios of the measured exposure values, X M , to calculated exposures, Xc, obtained with the dosimetry system. Average X M /X C ratios (+ 1 standard deviation) over ranges of clinical tube potentials and currents are given in Table 2 , together with the total number of individual data points obtained. A change in the source-topatient distance or the electronic magnification during continuous fluoroscopy resulted in an average X M /X C ratio of 1.04 t 0.03. Simulation of a nonstandard examination performed in the frontal plane with "maximized" changes made to all possible imaging parameters resulted in a computed skin dose of 0.98 Gy by the on-line patient exposure meter, whereas the measured value was 0.93 Gy (5% difference). In general, these results demonstrated that the dosimetry system Figure 2 shows the histogram distribution of the fluoroscopic skin dose measurements for the first 114 patients who underwent diagnostic and therapeutic neuroradiologic interventional procedures after installation of the dosimetry system. Median values of these skin dose measurements were 0.38 and 0.11 Gy in the frontal and lateral planes, respectively. Figure 3 shows the corresponding data for radiographic acquisitions, which were predominantly digital subtraction angiographic. For these radiographic imaging procedures, the median values of the skin dose measurements were 0.83 and 0.49 Gy in the frontal and lateral planes, respectively. Figure 4 shows the histogram distribution of the total skin dose measurements from all fluoroscopic and radiographic imaging procedures for all 114 patients. In the frontal plane, the median skin dose measurement was 1.20 Gy, with approximately two-thirds of Figures 2, 3 . . Histograms show distributions of total skin dose measurements in 114 patients from (2) fluoroscopy and (3) radiography in the frontal (gray bars) and lateral (black bars) will normally generate skin doses within 5% of the true skin dose.
System Accuracy RESULTS
Patient Doses
Volume 203 l Number 3 Radiology l 839 the dose due to radiographic acquisitions. In 29 (25%) patients, the skin dose measurement exceeded 2.00 Gy with a maximum of 5.00 Gy. In the lateral plane, the median skin dose measurement was 0.64 Gy, with threefourths of the dose due to radiographic acquisitions. The maximum skin dose measurement in the lateral plane (5.20 Gy) was similar to the maximum value (5.00 Gy) obtained for the frontal plane. In the lateral plane, 10 (9%) patients had skin dose measurements that exceeded 2.00 Gy. Figure 5 shows a histogram distribution of the average dose rates during fluoroscopy. Median dose rates were 34 and 30 mGy/min in the frontal and lateral planes, respectively. Figure 6 shows the data relating to skin dose per frame for radiographic images with median skin doses of 2.30 and 1.60 mGy per frame in the frontal and lateral planes, respectively.
Acquisition Technique Data Figure 7 shows the distribution of fluoroscopic image acquisition times for the 114 neuroradiologic procedures. The frontal plane was most frequently used, with a median value of 12 minutes per patient examination compared with a median value of 4 minutes for the lateral plane. The median number of times that the operator initiated fluoroscopy were 68 and 31 in the frontal and lateral planes, respectively. The median number of radiographic images (ie, digital subtraction angiographic frames) per patient examination were 377 and 325 in the frontal and lateral planes, respectively.
DISCUSSION
Most dosimetry data for patients undergoing diagnostic procedures are obtained with a free-in-air geometry (10, 11) . Free-in-air dosimetry data facilitate experimental measurements, permit direct comparison of data among facilities, and correspond to the dosimetric protocols used currently by the U.S. Center for Devices and Radiological Health (12) . For prediction of the possibility of occurrence of deterministic effects, however, the dosimetric parameter of primary interest is the patient skin dose. Consequently, our values of exposure measurements included backscatter and were converted into the corresponding absorbed skin doses. Any comparison of our dosimetry data with data obtained by using a free-in-air geometry would need to take both of these factors into account. The exposure to muscle dose conver- Figures 4-6. Histograms show distributions of (4) total skin dose measurements from fluoroscopy and radiography, (5) average patient skin dose rates from fluoroscopy, and (6) average patient skin doses per frame of digital subtraction angiography in the frontal (gray bars) and lateral (black bars) planes in 114 patients.
sion value used in our study (2.58 x 10 -4 C/kg, corresponding to an absorbed dose of 9.3 mGy) has a small dependence on photon energy of about 4% between 30-and 100-keV x rays (9) . Data on the fractional backscatter ranges are available in the literature and are about 0.15-0.30 for head radiographic projections, depending on x-ray beam quality and area (13) (14) (15) .
The accuracy and precision of the radiation measurements were both about 5%; this value is satisfactory for the purpose of determining the skin doses to patients undergoing neuroradiologic procedures. However, several factors may reduce the accuracy of the recorded patient skin doses. Use of a head stabilizer, for example, would change the geometry and has the potential to mislead the radiation monitoring system in determining the source-to-skin distance. Rotation of the x-ray beam or use of collimation during a radiologic procedure would clearly modify the skin region exposed to x rays, and variations of the x-ray intensity across the x-ray beam could introduce small errors to the computed skin doses. In addition, there is the possibility of electronic drifts resulting in calibration changes to the radiation monitoring system. Over a 2-year period, however, we have found this commercial on-line patient monitoring system to be stable with no need for recalibration.
well as patient age, genetic background, and hormonal status. One possible limitation of the on-line patient exposure meter is the fact that the irradiated region of interest may not be fixed as assumed in the skin dose measurements reported in our study. For any patient undergoing a neuroradiologic procedure, however, the operator can estimate the fraction of fluoroscopic and radiographic doses pertaining to the region receiving the highest radiation dose. This additional information may be appended to the radiation dose summary and used to identify those patients who may be at risk of incurring a deterministic radiation effect.
Patient skin doses are of interest primarily for the purpose of estimating the probability of a radiation-induced deterministic effect. The uncertainties of threshold doses for the induction of deterministic effects such as skin erythema or epilation are considerably larger than 5% (7, 16, 17) . Factors that may affect the threshold dose include the anatomic location and size of the irradiated region, tissue vascularity and oxygenation, as All initial angiograms obtained in a given vessel territory constituted complete coverage of arterial, capillary, and venous phases. Subsequent examinations of that vessel with various alterations in positioning (projection), magnification, and injection of contrast material were performed to specifically evaluate the visualized or anticipated pathologic condition. As a result, these examinations were limited to the arterial phase for aneurysms, acquisition of principal images in the capillary phase for tumors, and concentration on the venous phase for study of venous patency. Frontal fluoroscopy was used in the truncal and thoracic regions to visualize catheter manipulation and guidance. Biplane fluoroscopy of the head region was used for target position verification. Most digital subtraction angiographic acquisitions were performed by using biplane acquisitions with only occasional use of single-plane acquisitions. Single (frontal) plane imaging was used primarily to evaluate aneurysm origin with standard digital subtraction or rotational angiography.
induction of deterministic effects (2.00 Gy), we observed no cases of epilation or skin erythema in this series of 114 patients. This is not, surprising, since any erythema would be fleeting and faint. Epilation would be identified only by means of a slightly different amount of hair loss, as perceived when combing hair, and would not require total loss of hair. For acute radiation exposures, clearly observable effects such as total epilation are more likely to occur at doses in excess of 6 Gy (1). Another factor that needs to be considered in predicting the likelihood of deterministic effects to patients undergoing neuroradiologic examinations is that the radiation doses are delivered over an extended period; this period may be as long as several hours. In addition, the radiation field is varied depending on the region of the patient's body. For individuals with the highest exposures, the neuroradiologists generally make a concerted effort to move the relative orientation of the x-ray beam or to use the orthogonal imaging plane in so far as these options do not adversely affect the necessary imaging information. Many of the neuroradiologic imaging procedures also make use of wedge-shaped transparent filters, which serve to reduce the radiation doses at the periphery of the x-ray field of view while maintaining image quality within the central region.
Although up to 25% of the patients in our study may have exceeded the nominal threshold skin dose for the One strategy to reduce the radiographic skin doses is to increase the examination tube potential or increase filtration, which has the potential to achieve skin dose reductions of about 35% (18) . Radiographic tube potentials were generally higher in the frontal plane due to the greater x-ray path length for this projection through the patient's head. It may therefore be possible to reduce the patient skin dose by increasing the tube potential for lateral exposures; this increase in tube potential would produce a subject contrast comparable with that of the frontal plane.
Although an increase in the x-ray potential for either imaging plane may appear attractive, it is important to consider the corresponding reduction in subject and image contrast that would likely occur. The ability to visualize small and low-contrast objects is of paramount importance in neuroradiology, where neurovascular instruments may be as small as 200 km and vessel diameters are as small as 100 pm. Any dose reduction strategy must always ensure that image quality is not compromised and patients do not experience any adverse clinical consequences as a result of inadequate visualization of catheters or vasculature.
Imaging of an anthropomorphic phantom permitted experimental investigation of the effect of changing a range of parameters on patient dose and the corresponding image quality. There are three electronic magnification modes available with typical exposure rates in the frontal plane ranging from 35 (30-cm mode) to 56 (15-cm mode) mGy/min. Use of collimators was found to increase the skin dose from 15% to 25% as the large field of view was reduced by 50% by using collimation. The largest increases in skin dose were observed with changes in the position of the patient's head relative to the x-ray tube by changing the position of the table or by movement of the x-ray tube or the image intensifier. This latter factor was found to be of most practical importance, since it offered large reductions in patient dose (up to a factor of two) with negligible costs in terms of the resultant image quality.
Additional operational factors that could be used to reduce patient doses include limiting the use of magnification studies and reducing frame rates wherever possible. For example, it may be possible to use a frame rate of three frames per second during the high-flow arterial phase and less frequent imaging during the slower venous phase. Reduction of fluoroscopic dose rates to lower levels may also be possible in those instances where the additional mottle will not adversely affect the clinical imaging needs. Another attractive strategy for dose reduction is to use pulsed fluoroscopy with low pulse rates; use of this modality with reduced pulse rates has the potential of substantial reduction of patient doses while maintaining satisfactory image quality (19) . The application of pulsed fluoroscopy in a clinical setting clearly needs further study to investigate which pulse rates and exposure levels will result in optimal clinical performance. Modifications to current neuroradiologic imaging systems may also be necessary to improve the clinical applications of pulsed fluoroscopy. Examples of the latter would include the pulse rate, pulse duration, and the x-ray tube current.
Evaluation of our dosimetry data must take into consideration that these studies were obtained under the supervision of a staff neuroradiologist while training residents and fellows of various levels in an academic institution. Therefore, depending on the trainee's level of expertise in catheter manipulation and patient positioning, there can be large differences in fluoroscopic imaging time. In the context of an academic center where training must take place, the dose can potentially be decreased by means of an intensive in vitro training program with use of vascular models for training of catheter manipulation and use of an anthropomorphic phantom for head positioning before performance of a neuroradiologic procedure. The use of an on-line patient exposure meter is therefore particularly appropriate for an academic radiology department, where it may be used to educate future interventional radiologists to help keep patient doses as low as reasonably achievable.
Radiation exposure in neuroradiology may also be associated with the induction of stochastic risks such as radiation-induced carcinogenesis (20) . The entrance skin dose data reported in our study may be converted into values of effective dose; these values may be considered a relative measure of the stochastic radiation risk. With estimation of the average cross-sectional area of the x-ray beam, it is possible to determine the patient dose-area product value provided that use of wedgeshaped transparent filters during fluoroscopy is taken into account. The dosearea product may be subsequently converted into the corresponding value of effective dose by using published conversion factors (21, 22) . Patient effective doses in diagnostic neuroradiology are much lower than the corresponding entrance skin doses. In one study, the mean entrance skin dose from fluoroscopy was reported to be 270 mGy in 10 patients undergoing cerebral angiography, but the corresponding mean effective dose was estimated to be only 7.1 mSv (20) .
In conclusion, an on-line patient exposure meter can accurately and conveniently provide radiation skin dose data for patients undergoing diagnostic and therapeutic neuroradiologic procedures. Use of an on-line patient exposure meter can reduce the patient exposure by increasing the radiologist's awareness of the exposure rate and cumulative patient dose, provide a record of the patient exposure for the medical chart, and help identify those individuals who may incur a radiation-induced deterministic effect. An on-line patient exposure meter can also serve to improve our knowledge of the threshold doses for occurrence of deterministic effects from x-ray exposure. Dosimetry systems like the on-line patient exposure meter we evaluated can be a valuable tool for conducting investigations into the trade-offs between patient doses and the corresponding image quality by simulating examinations in which anthropomorphic phantoms are used, as well as serving as a useful educational aid for training new interventional radiologists. n
